Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
15.59
+0.42 (2.77%)
Jul 28, 2026, 3:14 PM EDT - Market open
Surgery Partners Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 182.3 | 239.9 | 269.5 | 195.9 | 282.9 | 389.9 |
Cash & Short-Term Investments | 182.3 | 239.9 | 269.5 | 195.9 | 282.9 | 389.9 |
Cash Growth | -20.50% | -10.98% | 37.57% | -30.75% | -27.44% | 22.65% |
Accounts Receivable | 603.4 | 602.2 | 579.1 | 496.4 | 456.3 | 430.2 |
Inventory | 100.5 | 96.6 | 88.4 | 75.2 | 71.4 | 61.1 |
Other Current Assets | 196.3 | 212 | 182.4 | 127.5 | 110.4 | 64.9 |
Total Current Assets | 1,083 | 1,151 | 1,119 | 895 | 921 | 946.1 |
Net Property, Plant & Equipment | 1,416 | 1,443 | 1,384 | 1,224 | 1,156 | 953.8 |
Other Intangible Assets | - | 41 | 45.7 | 54.8 | 42.3 | 43.7 |
Goodwill | - | 5,195 | 5,068 | 4,326 | 4,137 | 3,912 |
Long-Term Investments | 225.4 | 234 | 215.4 | 184.1 | 190.3 | 88.7 |
Other Long-Term Assets | 5,318 | 56.8 | 57.5 | 192.8 | 235.7 | 173.5 |
Total Assets | 8,042 | 8,120 | 7,890 | 6,877 | 6,682 | 6,118 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 168.6 | 208.7 | 208.7 | 171.8 | 151.6 | 124.9 |
Accrued Expenses | 77.1 | 64.9 | 60.4 | 73.8 | 68.9 | 77.1 |
Current Portion of Long-Term Debt | 100.4 | 99.3 | 101.4 | 73.3 | 62.8 | 60.4 |
Other Current Liabilities | 235.6 | 242.6 | 253.9 | 204.1 | 210.1 | 274.4 |
Total Current Liabilities | 581.7 | 615.5 | 624.4 | 523 | 493.4 | 536.8 |
Long-Term Debt | 3,614 | 3,603 | 3,269 | 2,702 | 2,559 | 2,878 |
Long-Term Leases | 271.9 | 279.9 | 292.1 | 248.9 | 271.4 | 315.6 |
Other Long-Term Liabilities | 93.7 | 94.6 | 69.4 | 41.1 | 75.4 | 87 |
Total Long-Term Liabilities | 3,979 | 3,977 | 3,630 | 2,992 | 2,906 | 3,281 |
Total Liabilities | 4,561 | 4,593 | 4,255 | 3,515 | 3,399 | 3,818 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 0.9 |
Additional Paid-in Capital | 2,548 | 2,541 | 2,521 | 2,498 | 2,478 | 1,622 |
Accumulated Other Comprehensive Income | -10.5 | -13.8 | 4.8 | 57.5 | 76.2 | -31.5 |
Retained Earnings | -851.1 | -815.2 | -737.3 | -569.2 | -557.3 | -502.7 |
Total Common Shareholders' Equity | 1,688 | 1,713 | 1,790 | 1,987 | 1,998 | 1,089 |
Minority Interest | 1,793 | 1,814 | 1,846 | 1,375 | 1,285 | 1,211 |
Shareholders' Equity | 3,481 | 3,527 | 3,635 | 3,362 | 3,283 | 2,300 |
Total Liabilities & Equity | 8,042 | 8,120 | 7,890 | 6,877 | 6,682 | 6,118 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3,986 | 3,982 | 3,662 | 3,024 | 2,893 | 3,254 |
Net Cash (Debt) | -3,804 | -3,742 | -3,393 | -2,828 | -2,610 | -2,865 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -29.80 | -29.42 | -26.90 | -22.51 | -28.39 | -39.55 |
Book Value | 1,688 | 1,713 | 1,790 | 1,987 | 1,998 | 1,089 |
Book Value Per Share | 13.22 | 13.47 | 14.19 | 15.82 | 21.73 | 15.04 |
Tangible Book Value | 1,688 | -3,523 | -3,324 | -2,394 | -2,181 | -2,867 |
Tangible Book Value Per Share | 13.22 | -27.69 | -26.36 | -19.06 | -23.72 | -39.58 |